Articles On Regeneus (ASX:RGS)

Title Source Codes Date
Crucible: Dr Boreham’s A-To-Z of 2024 biotech

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

Stockhead RGS 6 days ago
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally

The ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector.  Lithium stocks led, with IGO (ASX:IGO) and Pilbara (ASX:PLS) gaining around 3%.  Iron ore miners  rallied after the Nymex CFR China, 62% Fe price swu...

Stockhead RGS 8 months ago
Closing Bell: Gains in Gold and Tech stocks offset by losses in Energy as oil price retreats

The ASX200 closed up slightly by +0.1% on Monday as gains in tech and gold stocks were offset by losses in the energy sector.  Energy stocks struggled as crude prices fell more than US$1 a barrel in Asian hours today after Israel confirmed...

Stockhead RGS 8 months ago
Top 10 at 10: 3D printed engines and a rejected takeover bid

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead RGS 8 months ago
Regeneus trebles on back of merger deal

This week’s Bulls N’ Bears ASX Runner of the Week is… Regeneus Ltd. Its share price surged 220 per cent to join fellow movers and shakers Acrux Ltd and Perpetual Resources.

The West RGS 8 months ago
Regeneus and Cambium merge to refine dry eye treatment development

Australian regenerative medicine firm Regeneus (ASX: RGS) and US-headquartered Cambium Medical Technologies (CMT) have completed a merger that will see them combine to further develop a novel biologic treatment for dry eye disease. Regeneus...

smallcapsau.mystagingwebsite.com RGS 8 months ago
Closing Bell: ASX ends higher but iron’s ordinary problem isn’t going away

  Local markets give up early gains then regains them, closing 0.22pc higher Consumer Discretionary stocks offset losses in materials and Energy  Small Caps led by LBT Innovations   It’s hard to stay afloat when BHP sinks to a near nine-m...

Stockhead RGS 9 months ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead RGS 9 months ago
Closing Bell: Local markets in a sulk for the cut that won’t come

ASX200 ends 0.75pc lower after a long slog back from -1.5pc this morning. Industrial Sector only gainer, thanks to a banger from Downer Edi Small caps led by Blue Star Helium, Rox Resources.   Local share markets trimmed early losses b...

Stockhead RGS 10 months ago
Top 10 at 11: Helium and lithium are bright spots on a fairly grim ASX morning.

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead RGS 10 months ago
Closing Bell: The ASX is slightly higher, but not much cooler on Monday

The ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose over the weekend Small caps led Killi Resources, Nyrada and Viridis Mining   The Aussie sharemarket has ended the opening salvo of the week...

Stockhead RGS 1 year ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead RGS 1 year ago
ASX October winners: The 50 best ASX stocks as Israel-Hamas escalation adds further pressure to fragile markets

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Stockhead RGS 1 year ago
Closing Bell: Mega miners leave ASX with barely a thread after giving it all away on weak China data

Benchmark ASX crawls back to close +0.12% in the green Seven Sectors close higher, led by REITs and Consumer stocks Small caps led by TOY and Patriot Lithium   The benchmark has ended a good morning with a wretched afternoon, as selling a...

Stockhead RGS 1 year ago
Closing Bell: It certainly wasn’t cricket as Monday markets in Australia knocked right back to last year

Benchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sectors on Monday Small caps led by CHM, TON   On Monday Aussie markets rediscovered their nadir of the year. No real surprises, since every n...

Stockhead RGS 1 year ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead RGS 1 year ago
Top 10 at 11: Juicy berries and autonomous cop drones got the market jingling this morning

Stockhead’s Top 10 at shortly-before-11-ish, produced with gritted teeth as, once again, the local council has decided that it needs to pay some drongo to stand outside my house all day waving a leaf blower around while screaming into his c...

Stockhead RGS 1 year ago
Closing Bell: Small cap biopharma injects a little excitement as ASX finally finds a Thursday butt to kick

Benchmark index finds some rare greenage, up 0.5% Property and IT Sectors lead broad-based gains, XEC Emerging Co’s index now down 14% from July highs Fascinating small caps action: led by Dimerix, Bluglass and Experience Co.   The ASX2...

Stockhead RGS 1 year ago
In Case You Missed It: Kidney drug licensing deal and semiconductor club membership

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead RGS 1 year ago
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet

Benchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors edge higher, but Health Care anchors the benchmark into the red Small caps led by Galileo Mining, Infinity and last week’s rockstar Biotron...

Stockhead RGS 1 year ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead RGS 1 year ago
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy

Benchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in the red Small caps led by NickelSearch and Biotron A positive lead from Wall Street overnight didn’t sell well on local markets, which were...

Stockhead RGS 1 year ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead RGS 1 year ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead RGS 1 year ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead RGS 1 year ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead RGS 1 year ago
CLOSING BELL: CBA makes bank from rising rates, then issues a warning about mortgage arrears

Local markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts record $10.2 billion profit off the back of ever-increasing interest rates. Small capper Perpetual stuns with a 50% spike after buying up land in...

Stockhead RGS 1 year ago
Top 10 at 10: West Cobar Metals expands clay REE resource; plus more North American lithium love

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead RGS 1 year ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead RGS 1 year ago
Closing Bell: Soft landing chatter picks up as Tech and Real Estate stocks surge

The ASX 200 had another fine day, ending with a 0.73% gain overall Sectors wise, Tech and Real Estate were the winners, while Materials dipped as a whole, partly due to Rio and Fortescue  Standout small-cap performers: R3D, PAC, and the ju...

Stockhead RGS 1 year ago
Closing Bell: ASX 200 finishes week with a red day, but at least a sand stock (PEC) is well up

The ASX 200 started poorly, got worse, and only picked up marginally in the arvo (-0.15%) Sectors wise, IT had a shocker after it saw what happened to Tesla and Netflix share prices in the US Notable performers today, though: sand stock PE...

Stockhead RGS 1 year ago
TMH: Market Close: All sectors end in the green

Fortescue Metals Group (FMG) has traded up 1 per cent despite news that founder Andrew Forrest and his wife, Nicola, have separated after 31 years of marriage.  The couple released a ‘private statement’ to the ASX today, saying there wou...

themarketherald.com.au RGS 1 year ago
Closing Bell: ASX finishes in the green, Real Estate leads the charge

The ASX 200 finishes up 1.56%  The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Estate   The ASX 200 managed a decent 1.56% lift today, and the ASX XEC was also in the green, up 1.52%.  All of 11 sectors were higher, led b...

Stockhead RGS 1 year ago
CLOSING BELL: Investors in pain as ASX falls 1.69% to 50-day low

The S&P ASX 200 closes 1.69% lower setting new 50-day low, with Emerging Companies index also falling Golden Deeps uncovers in-demand germanium and gallium at Nosib vanadium-copper-lead-silver discovery AdAlta announces new data pointi...

Stockhead RGS 1 year ago
CLOSING BELL: Another red day on the ASX as Fed eyes ‘mild recession’ and big miners dip

S&P/ASX 200 closes well in the red today: -1.24% after US stocks dipped on the back of Fed hawkishness  Sectors-wise, IT was the only group finishing vaguely in the green, with Materials Discretionary and Financials stocks largely hamm...

Stockhead RGS 1 year ago
CLOSING BELL: ASX falters with no US market to copy today

S&P/ASX 200 closes in the red today: -0.35%, as US stock markets enjoy a July 4 chilli dog, or something Sectors-wise, Telcos are ringing in the gainz… annnd that’s about it. Okay, Utilities are going alright  Standout stocks: Krakatoa...

Stockhead RGS 1 year ago
ASX June Winners: Who rode this lithium junior to seven-bagger status in June?

The S&P ASX 200 was up 1.76% in June, with large caps performing the best and small caps lagging blue chips The S&P/ASX 200 Materials was the best performing sector in June, up 4.8% coming back from April drop An ASX favourite lith...

Stockhead RGS 1 year ago
CLOSING BELL: Investors respond to the government’s Critical Minerals Strategy by selling everything in sight

Aussie markets are down 0.6% after the gubbermint dropped an unpopular look at the future. Gold stocks, Energy, Materials, Resources, Metals and miners are all well below the broader market. Iris Metals bucked the trend, out of the ASX dog...

Stockhead RGS 1 year ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead RGS 1 year ago
CLOSING BELL: Local markets climbed 0.86% today, but those sods at the RBA want you out of a job.

The ASX 200 climbed 0.86% today, after the RBA said it wants you all to get fired. Energy stocks climb 1.94% after I dared to turn my heater on this morning. Brightstar is thiiiis close to actual gold production, up 30% today as a result....

Stockhead RGS 1 year ago
CLOSING BELL: Remember to say thanks to the techies, without whom we’d be deep in the red for the day

Local markets shook off a post-long-weekend wobble to end the day higher, up 0.23% It’s been another red-hot day for the techies, with that sector up by 3.7%. Health techie AHI went flying 370% this morning, and it’s anyone’s guess as to w...

Stockhead RGS 1 year ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead RGS 1 year ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead RGS 1 year ago
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

Stockhead RGS 1 year ago
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Stockhead RGS 1 year ago
CLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds

ASX falls 0.17% ahead of Chalmers dropping The Budget on the nation Financials led the pack today, adding 0.5% on an otherwise fairly moribund day Voltaic Strategic Resources climbs 188% on pre-assay lithium results at Ti Tree   The ASX h...

Stockhead RGS 1 year ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead RGS 1 year ago
CLOSING BELL: Despite another charge on gold, the ASX has limped to a -0.08% close

ASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners again, up 1.96% and well ahead of the market Mt Monger does well with a 23% gain to be over +130% for the month   After an early grimace-indu...

Stockhead RGS 1 year ago
CLOSING BELL: Iron ore price plunge leads the ASX lower, leaving REEs to rule the roost

ASX 200 benchmark closes 0.11% lower after a fickle day on the bourse Iron ore price drops to five month lows, making (almost) everyone sad Larvotto ends up on top of the Small Caps, adding 61.9% for the day   Aussie markets were a tad me...

Stockhead RGS 1 year ago
Closing Bell: ASX falls, energy stocks rally as Russia threatens to slash oil production

The ASX 200 fell 0.21% and the ASX XEC slips 1.05% A 8 out of 11 sectors were lower led by Consumer Discretionary down 1.40% Energy sector and stocks rally after Russia announces plans to slash oil production   The ASX 200 dropped 0.21% t...

Stockhead RGS 1 year ago